Boxer Capital Portfolio
13F Holdings & Position Changes — Last filed Feb 14, 2025
13F Holdings & Position Changes — Last filed Feb 14, 2025
Boxer Capital is a $2B biotech-focused hedge fund managed by Aaron Davis. As of their latest 13F filing (Q4 2024), the fund holds 1 positions worth $0. This quarter they initiated 1 new position. Their largest holding is IMA ($0).
Boxer initiated 1 new position this quarter.
Showing first tracked quarter (Dec 31, 2024) — historical comparison will be available after the next 13F filing cycle.
No credit card required
Boxer Capital holds 1 biotech stocks in their 13F portfolio. Their top positions include IMA. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
Boxer Capital's tracked biotech portfolio is worth $0 across 1 positions, with total assets under management of approximately $2B. Portfolio values are based on 13F filings with the SEC.
Boxer Capital initiated 1 new position this quarter, including IMA. They also increased 0 existing positions.
Boxer Capital did not fully exit any positions this quarter.
San Diego-based biotech specialist investing across the full drug development lifecycle from preclinical through commercial. Takes concentrated positions with deep scientific due diligence, leveraging proximity to the Southern California biotech cluster.